Insulin Market

Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and Human Insulin) - Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume) 2013 - 2019

  • Rep Id : TMRGL259
  • Published On : Jun 2014
  • No. of Pages : 99
  • Category : Healthcare

 

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

      1.3.1 Sources

               1.3.1.1 Secondary Research

               1.3.1.2 Primary Research

      1.3.2 Assumptions

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Insulin Market (2012 & 2019)

2.2 Market Snapshot: China Insulin Market (2012 & 2019)

 

Chapter 3 Market Overview

3.1 Overview

3.2 Market Drivers

      3.2.1 Global rise in diabetic population

      3.2.2 No strict regulations on price capping

      3.2.3 High entry barriers for biosimilar manufacturers

3.3 Market Restraints

      3.3.1 Growing acceptance of SGLT2 and GLP-1 agents among type 2 diabetes patients will delay the shift to insulin therapy

      3.3.2 High cost of products restrains the uptake of insulin in emerging markets

3.4 Market Opportunities

      3.4.1 Development of combination products

      3.4.2 Strong Pipeline

3.5 Value Chain: Global Insulin Market

3.6 Porter’s Five Force Analysis of the Global Insulin Market

      3.6.1 Bargaining power of suppliers

      3.6.2 Bargaining power of buyers

      3.6.3 Threat of substitutes

      3.6.4 Threat of new entrants

      3.6.5 Competitive rivalry

3.7 Market Attractiveness Analysis: Global Insulin Market, by Mode of Action

 

Chapter 4 Global Insulin Market, by Mode of Action

4.1 Overview

      4.1.1 Characteristics of type of Insulin

      4.1.2 Global Insulin Market Revenue, by Mode of Action, 2011 – 2019 (USD Million)

      4.1.3 Global Insulin Market Volume, by Mode of Action, 2011 – 2019 (tMU)

      4.1.4 Comparative Analysis: Global Insulin Market Revenue, by Mode of Action, 2012 & 2019 (Value %)

4.2 Short-Acting Insulin

      4.2.1 Global Short-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

      4.2.2 Global Short-Acting Insulin Market Volume, 2011 – 2019 (tMU)

4.3 Rapid-Acting Insulin

      4.3.1 Global Rapid-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

      4.3.2 Global Rapid-Acting Insulin Market Volume, 2011 – 2019 (tMU)

      4.3.3 Pipeline Analysis

               4.3.3.1 Afrezza

                          4.3.3.1.1 Global Afrezza Market Revenue, 2015 – 2019 (USD Million)

               4.3.3.2 NN1218 (FIAsp)

                          4.3.3.2.1 Global NN1218 Market, 2016 – 2019 (USD Million)

4.4 Long-Acting Insulin

      4.4.1 Global Long-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

      4.4.2 Global Long-Acting Insulin Market Volume, 2011 – 2019 (tMU)

      4.4.3 Pipeline Analysis

               4.4.3.1 LY2605541(Novel Basal Insulin Analog)

                          4.4.3.1.1 Global LY2605541 Market Revenue, 2015 – 2019 (USD Million)

               4.4.3.2 LY2963016 (Long acting basal insulin)

                          4.4.3.2.1 Global LY2963016 Market Revenue, 2014 – 2019 (USD Million)

               4.4.3.3 MK-1293 (Sustained release insulin analog)

                          4.4.3.3.1 Global MK-1293 Market Revenue, 2016 – 2019 (USD Million)

               4.4.3.4 U-300 (Toujeo)

                          4.4.3.4.1 Global U-300 Market Revenue, 2015 – 2019 (USD Million)

               4.4.3.5 IDegLira (Xultophy)

                          4.4.3.5.1 Global IDegLira Market Revenue, 2014 – 2019 (USD Million)

4.5 Intermediate-Acting Insulin

      4.5.1 Global Intermediate-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

      4.5.2 Global Intermediate-Acting Insulin Market Volume, 2011 – 2019 (tMU)

4.6 Premixed Insulin

      4.6.1 Global Premixed Insulin Market Revenue, 2011 – 2019 (USD Million)

      4.6.2 Global Premixed Insulin Market Volume, 2011 – 2019 (tMU)

 

Chapter 5 China Insulin Market, by Mode of Action

5.1 Overview

5.2 Breakdown of insulin-dependent population in China (2009)

      5.2.1 China Insulin Market Revenue, by Mode of Action, 2011 – 2019 (USD Million)

      5.2.2 China Insulin Market Volume, by Mode of Action, 2011 – 2019 (tMU)

5.3 Short-Acting Insulin

      5.3.1 China Short-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

      5.3.2 China Short-Acting Insulin Market Volume, 2011 – 2019 (tMU)

5.4 Rapid-Acting Insulin

      5.4.1 China Rapid-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

      5.4.2 China Rapid-Acting Insulin Market Volume, 2011 – 2019 (tMU)

5.5 Long-Acting Insulin

      5.5.1 China Long-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

      5.5.2 China Long-Acting Insulin Market Volume, 2011 – 2019 (tMU)

5.6 Intermediate-Acting Insulin

      5.6.1 China Intermediate-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

      5.6.2 China Intermediate -Acting Insulin Market Volume, 2011 – 2019 (tMU)

5.7 Premixed Insulin

      5.7.1 China Premixed Insulin Market Revenue, 2011 – 2019 (USD Million)

      5.7.2 China Premixed Insulin Market Volume, 2011 – 2019 (tMU)

 

Chapter 6 Global Insulin Market, by Source

6.1 Overview

      6.1.1 Global Insulin Market Revenue, by Source, 2011 – 2019 (USD Million)

      6.1.2 Global Insulin Market Volume, by Source, 2011 – 2019 (tMU)

6.2 Human Insulin

      6.2.1 Global Human Insulin Market Revenue, 2011 – 2019 (USD Million)

      6.2.2 Global Human Insulin Market Volume, 2011 – 2019 (tMU)

6.3 Modern Insulin

      6.3.1 Global Modern Insulin Market Revenue, 2011 – 2019 (USD Million)

      6.3.2 Global Modern Insulin Market Volume, 2011 – 2019 (tMU)

 

Chapter 7 China Insulin Market, by Source

7.1 Overview

      7.1.1 China Insulin Market Revenue, by Source, 2011 – 2019 (USD Million)

      7.1.2 China Insulin Market Volume, by Source, 2011 – 2019 (tMU)

7.2 Human Insulin

      7.2.1 China Human Insulin Market Revenue, 2011 – 2019 (USD Million)

      7.2.2 China Human Insulin Market Volume, 2011 – 2019 (tMU)

7.3 Modern Insulin

      7.3.1 China Modern Insulin Market Revenue, 2011 – 2019 (USD Million)

      7.3.2 China Modern Insulin Market Volume, 2011 – 2019 (tMU)

 

Chapter 8 Competitive Landscape

8.1 Market Share Analysis: Global Insulin Market, 2012 (%)

      8.1.1 Global Insulin Market Share Analysis, by Key Players, 2012 (%)

8.2 Market Share Analysis: China Insulin Market, 2012 (%)

      8.2.1 China Insulin Market Share Analysis, by Key Players, 2012 (%)

 

Chapter 9 Recommendations

9.1 Development of formulations that can be administered by different routes

9.2 Development of combination formulations

9.3 Overcoming technical incompatibilities

9.4 Focus on emerging markets

 

Chapter 10 Company Profiles

10.1 Eli Lilly and Company

      10.1.1 Company Overview

      10.1.2 Financial Overview

      10.1.3 Product Portfolio

      10.1.4 Business Strategies

      10.1.5 Recent Developments

10.2 Novo Nordisk A/S

      10.2.1 Company Overview

      10.2.2 Financial Overview

      10.2.3 Product Portfolio

      10.2.4 Business Strategies

      10.2.5 Recent Developments

10.3 Sanofi

      10.3.1 Company Overview

      10.3.2 Financial Overview

      10.3.3 Product Portfolio

      10.3.4 Business Strategies

      10.3.5 Recent Developments

10.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

      10.4.1 Company Overview

      10.4.2 Financial Overview

      10.4.3 Business Overview

      10.4.4 Recent Developments

List of Tables

 

TABLE 1 Market Snapshot: Global Insulin Market (2012 & 2019)

TABLE 2 Market Snapshot: China Insulin Market (2012 & 2019)

TABLE 3 Global Insulin Market Revenue, by Mode of Action, 2011 – 2019 (USD Million)

TABLE 4 Global Insulin Market Volume, by Mode of Action, 2011 – 2019 (tMU)

TABLE 5 China Insulin Market Revenue, by Mode of Action, 2011 – 2019 (USD Million)

TABLE 6 China Insulin Market Volume, by Mode of Action, 2011 – 2019 (tMU)

TABLE 7 Global Insulin Market Revenue, by Source, 2011 – 2019 (USD Million)

TABLE 8 Global Insulin Market Volume, by Source, 2011 – 2019 (tMU)

TABLE 9 China Insulin Market Revenue, by Source, 2011 – 2019 (USD Million)

TABLE 10 China Insulin Market Volume, by Source, 2011 – 2019 (tMU)

List of Figures

 

FIG. 1 Insulin: Market Segmentation

FIG. 2 Global Insulin Market Revenue, by Mode of Action, 2012 (USD Million)

FIG. 3 China Insulin Market Revenue, by Mode of Action, 2012 (USD Million)

FIG. 4 Value Chain: Global Insulin Market

FIG. 5 Porter’s Five Forces Analysis: Global Insulin Market

FIG. 6 Market Attractiveness Analysis: Global Insulin Market, by Mode of Action

FIG. 7 Comparative Analysis: Global Insulin Market Revenue, by Mode of Action 2012 & 2019 (Value %)

FIG. 8 Global Short-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 9 Global Short-Acting Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 10 Global Rapid-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 11 Global Rapid-Acting Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 12 Global Afrezza Market Revenue, 2015 – 2019 (USD Million)

FIG. 13 Global NN1218 Market Revenue, 2016 – 2019 (USD Million)

FIG. 14 Global Long-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 15 Global Long-Acting Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 16 Global LY2605541 Market Revenue, 2015 – 2019 (USD Million)

FIG. 17 Global LY2963016 Market Revenue, 2014 – 2019 (USD Million)

FIG. 18 Global MK-1293 Market Revenue , 2016 – 2019 (USD Million)

FIG. 19 Global U-300 Market Revenue, 2015 – 2019 (USD Million)

FIG. 20 Global IDegLira Market Revenue, 2014– 2019 (USD Million)

FIG. 21 Global Intermediate-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 22 Global Intermediate-Acting Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 23 Global Premixed Market Revenue, 2011 – 2019 (USD Million)

FIG. 24 Global Premixed Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 25 Breakdown of insulin-dependent population in China (2009)

FIG. 26 China Short-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 27 China Short-Acting Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 28 China Rapid-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 29 China Rapid-Acting Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 30 China Long-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 31 China Long-Acting Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 32 China Intermediate-Acting Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 33 China Intermediate-Acting Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 34 China Premixed Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 35 China Premixed Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 36 Global Human Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 37 Global Human Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 38 Global Modern Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 39 Global Modern Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 40 China Human Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 41 China Human Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 42 China Modern Insulin Market Revenue, 2011 – 2019 (USD Million)

FIG. 43 China Modern Insulin Market Volume, 2011 – 2019 (tMU)

FIG. 44 Global Insulin Market Share Analysis, by Key Players, 2012 (%)

FIG. 45 Global Insulin Market Share Analysis, by Key Players, 2012 (%)

FIG. 46 Eli Lilly and Company: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 47 Novo Nordisk A/S.: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 48 Sanofi: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 49 Shanghai Fosun Pharmaceutical Co., Ltd.: Annual Revenue, 2011 – 2013 (USD Million)